After the approval letter: continuing review, reporting, and closing the study
The approval letter is usually filed and forgotten, which is why the second half of a study's relationship with the board is where avoidable trouble lives. Approval is a dated permission with duties attached: it can lapse, it can require a progress report, it obliges you to tell the board certain things promptly, and it has to be ended deliberately rather than simply stopped.
The short answer
Approval carries an expiry. Where the board requires continuing review, a progress submission goes in before that date or the study lapses. Between reviews, unanticipated problems and noncompliance are reported promptly. When the work ends, the study is formally closed rather than abandoned.
Does every approved GCU study need continuing review?
No — and this is the question most worth getting right, because the answer differs by how your study was reviewed and it is not yours to assume. Under the revised Common Rule, 45 CFR 46.109(f) releases three kinds of work from continuing review unless the board decides otherwise: research that was eligible for the expedited procedure, research handled under the limited-review provisions attached to certain exempt categories, and a study that has progressed until nothing remains but data analysis or follow-up clinical data already part of what was approved. GCU's own expedited review procedure carries the matching note: continuing review for research initially approved using expedited procedures is no longer required.
Read that release carefully, though. A board may decide otherwise, and it records why when it does: 45 CFR 46.115(a)(3) requires the board to keep records of continuing review activity, including its reasoning whenever it keeps reviewing work the rule would have let go. Meanwhile GCU's portal keeps an Expired status in its vocabulary, describing a study as expiring unless a continuing review has been submitted. The reconciliation is simple: what governs your study is the expiry printed on your own approval, not the general rule you read about someone else's.
For studies read by the convened board, continuing review is the norm, and GCU's procedure treats the interval as the board's own decision at approval — shortened wherever it wants closer oversight, or where more frequent progress reports would help.
When does the clock actually start?
Not when the letter reaches you. GCU's convened-review procedure is unusually specific here, and the detail is the one that catches people: a protocol approved at a convened meeting runs its approval period from the date of that meeting, and a protocol that required specific minor revisions but was otherwise approvable also runs from the date of the last convened meeting at which it was discussed — irrespective of when the responses were reviewed and the approval affirmed. In other words, the time you spend answering minor revisions comes out of your approval period, not out of the board's.
The consequence is a planning one. Read the expiry on the letter as the real deadline for all of data collection, and prepare any continuing review well ahead of it rather than waiting for a reminder. A lapse is not repairable by explanation.
What does a continuing review submission have to carry?
GCU's convened-review procedure lists the materials, and the list is a useful template even where a different route applies, because it tells you what the board wants to know about a study in flight.
| Element | What it establishes |
|---|---|
| The re-approval request itself | That you are asking for the study to continue, on the record, before the current permission ends |
| A summary of the protocol and every amendment | What the study is now, as opposed to what it was when first approved |
| Numbers and description of participants enrolled so far | Whether recruitment is going as described, and whether the population reached is the population approved |
| Adverse events beyond what was anticipated | Any harm occurring more often or more seriously than the approved risk assessment predicted |
| Unanticipated problems involving risk | Anything not previously reported that changes the risk picture for participants or others |
| Withdrawals and complaints | Whether participants are leaving, and whether anyone has objected to how the study is being run |
| Relevant new literature or findings | Whether the outside world has changed what is known about the risks involved |
| The current consent document | That the document in use is the document the board approved, in the version now in circulation |
| A progress report on the work to date | The narrative the board reads alongside the numbers |
Two of those deserve emphasis. The consent document matters because a continuing review with recruitment still open is the natural moment for the board to check that participants are still being enrolled on the approved terms. And the summary of amendments matters because it is the point at which a study that has drifted through several small modifications gets read as a whole again. If the modifications were handled cleanly — one complete protocol, revision dates marked — this is straightforward. If they were not, this is where it surfaces. How changes to an approved study are handled covers keeping that record clean.
GCU's procedure also contemplates something researchers rarely expect: verification from sources other than the investigator that nothing material has changed since the previous review, where the board thinks it appropriate. That authority sits in the federal rule too, at 45 CFR 46.108(a)(3)(ii). It is not an accusation — only a reminder that the board's confidence in a running study is not built from the researcher's account alone.
What has to be reported between reviews?
Some things do not wait for a scheduled report. The federal rule requires institutions to have written procedures for prompt reporting to the board, to institutional officials and to the relevant federal office of unanticipated problems involving risk to participants or to anyone else, serious or continuing noncompliance, and any suspension or termination of an approval — 45 CFR 46.108(a)(4). GCU's convened-review procedure carries the matching submission expectations: the completed adverse event or unanticipated problem form, a proposed corrective action plan where one applies, and a revised consent or protocol with the reasons for the change.
What counts as reportable is a judgement, and it is one worth making early rather than defensively. Four categories arise constantly in doctoral work and are easy to talk yourself out of reporting:
- A confidentiality event. A file emailed to the wrong recipient, a recording left in a shared folder, a transcript with names still in it. The harm is informational, and it is exactly the kind of risk the consent made promises about.
- A participant enrolled outside the approved criteria. Even a single one, and even where nobody was harmed.
- A procedure carried out differently from the approved description. A longer interview, an extra question, a second contact attempt the protocol did not describe.
- Distress that the risk assessment did not predict. Particularly in interview work on sensitive subjects.
The instinct to wait and see is the one to resist. A board that learns about something promptly is reading a compliance record; a board that learns about it late is reading a pattern.
How is a study closed?
Deliberately, and with a final account. A closure submission is not an administrative courtesy — it is the document that tells the board what the study finally did, and GCU's portal treats the closure form as serving that final-report purpose, which is why it expects the form to be completed in full rather than skimmed.
Before closing, work through the honest checklist:
- Is all interaction with participants finished? No follow-up contact, no member checking, no additional recruitment held in reserve.
- Is the data still identifiable? A study that has moved to analysis of an identifiable dataset has not ended for the board's purposes even though it has ended for the participants.
- Has everything reportable been reported? Closure is not the place to disclose something for the first time.
- Do the data-handling promises still hold? Storage, access and destruction were described in the approved file; closure does not release you from them, and the destruction date you promised is a date you keep.
- Are the records intact? The institution retains its own record of the study after completion under 45 CFR 46.115(b), and correspondence between board and investigator is part of it.
Closing well matters beyond tidiness. A closed study with a complete record is the one that survives a later question about how the data were obtained — from a journal, an employer, or a committee reading the manuscript years afterwards.
What if approval has already lapsed?
Stop collecting, and go to the board rather than around it. Research activity conducted after an approval has expired is not covered by that approval, and the route back is set by GCU's current doctoral handbook or IRB portal rather than by anything that can be assumed here. What we can say is that the file that recovers fastest is the one that arrives with an accurate account of what happened, what was collected and when, and a plan for what happens to anything collected outside the approval period. Concealment is the only version of this that cannot be repaired.
What to do next
Send us your approval letter. The free application review reads it for what it actually obliges you to do — the expiry, any condition attached to it, whether continuing review applies to your study as approved, and what a progress or closure submission will have to carry when the time comes. Amendments and continuing review are part of what this desk carries end to end after approval; how it works sets out where that sits, and the process step by step shows the whole route from determination to letter. Nothing about the research itself changes hands, and nothing about the ruling ever does.
Sources
- GCU IRB — Procedure for Review by Convened IRB (continuing review materials, approval periods)
- GCU IRB — Expedited Review Procedure (note on continuing review)
- GCU — How to Track the Status of Your iRIS Application (study status definitions)
- GCU Research — Institutional Review Board
- 45 CFR 46.109(f) — when continuing review is not needed
- 45 CFR 46.108 — Written procedures, prompt reporting, verification
- 45 CFR 46.115 — records the institution keeps
Where this article and GCU's own materials differ, GCU's current doctoral handbook or IRB portal governs. gcuirb is an independent practice and is not affiliated with, endorsed by or connected to Grand Canyon University.